Valuation: Avantor, Inc.

Market Cap 7.09B 6.2B 5.72B 5.29B 10.03B 677B 10.2B 68.38B 26.85B 333B 26.64B 26.06B 1,146B P/E 2026 *
28.9x
P/E 2027 * 24.1x
Enterprise Value 10.11B 8.84B 8.15B 7.53B 14.29B 964B 14.53B 97.42B 38.26B 475B 37.94B 37.12B 1,632B EV / Sales 2026 *
1.55x
EV / Sales 2027 * 1.42x
Free-Float
95.54%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 17/08/2025
Director of Finance/CFO 50 23/06/2026
Chief Operating Officer - 09/11/2025
Director TitleAgeSince
Director/Board Member 60 21/04/2020
Chairman 69 31/12/2025
Director/Board Member 62 30/09/2021
Date Insider Type Main position Quantity % Market Cap.
06-20Tax

Executive/Senior Manager

-3,010 0.0004%
05-07Buy

Director

10,000 0.0015%
05-06Free

Director

25,270 0.0037%
Change 5-day change 1-year change 3-year change Capi.($)
-1.14%+0.68% - - 7.09B
-0.50%-1.54%-28.85%-12.62% 164B
+1.80%+0.82%-6.73%-3.92% 107B
+0.32%+2.34%+2.79%+57.04% 59.04B
+0.79%-3.68%+39.99%+54.50% 51.72B
+0.72%-3.88%-13.66%-41.41% 41.87B
+0.47%-4.98% - - 34.7B
+2.66%+5.21%-10.09%-42.88% 28.93B
-1.10%-3.29%+55.70%-5.76% 24.99B
0.00%-1.01%-5.28%-3.57% 21.05B
Average +0.40%-0.86%+4.23%+0.17% 54.04B
Weighted average by Cap. +0.48%-0.91%-5.60%+1.02%

Financials

2026 *2027 *
Net sales 6.5B 5.69B 5.25B 4.85B 9.19B 620B 9.35B 62.68B 24.61B 305B 24.41B 23.88B 1,050B 6.64B 5.81B 5.36B 4.95B 9.39B 633B 9.55B 64B 25.13B 312B 24.93B 24.39B 1,072B
Net income 244M 213M 197M 182M 345M 23.26B 351M 2.35B 923M 11.46B 916M 896M 39.39B 289M 253M 233M 215M 409M 27.56B 416M 2.79B 1.09B 13.58B 1.09B 1.06B 46.68B
Net Debt 3.01B 2.63B 2.43B 2.24B 4.26B 287B 4.33B 29.04B 11.4B 142B 11.31B 11.06B 487B 2.36B 2.07B 1.91B 1.76B 3.34B 225B 3.4B 22.77B 8.94B 111B 8.87B 8.68B 382B
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Employees
13,500
Date Price Change Volume
10/07/26 US$10.39 -1.14% 6,654,980
09/07/26 US$10.51 +7.68% 9,119,663
08/07/26 US$9.760 -4.31% 6,986,828
07/07/26 US$10.20 -1.64% 6,932,139
06/07/26 US$10.37 +0.48% 7,512,090
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
10.39USD
Average target price
10.06USD
Spread / Average Target
-3.15%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AVTR Stock